AboutContactSponsorship
Cronicle Press Logo

biotech-startup-funding

Ann Arbor's Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech

Ann Arbor's Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech

Asalyxa Bio, Inc., a biopharmaceutical startup developing nano-engineered, immune cell-targeted therapeutics, just announced the closing of…

Ann Arbor's Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech

© 2018-2024 Cronicle Press LLC. All Rights Reserved. All text and photos not attributed copyright Cronicle Press. This content may not be copied or distributed except in excerpt with permission.